New predictors of outcome in idiopathic pulmonary arterial hypertension
- 1 January 2005
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 95 (2), 199-203
- https://doi.org/10.1016/j.amjcard.2004.09.006
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 26 references indexed in Scilit:
- Surrogate end points for pulmonary arterial hypertensionAmerican Heart Journal, 2004
- Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Long-term intravenous epoprostenol infusion in primary pulmonary hypertensionJournal of the American College of Cardiology, 2002
- Assessment of Survival in Patients With Primary Pulmonary HypertensionCirculation, 2002
- Bosentan Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine, 2002
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Primary pulmonary hypertension: natural history and the importance of thrombosis.Cell Metabolism, 1984